etoposide has been researched along with Lymphoma, T-Cell, Cutaneous in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Amagai, R; Asano, Y; Fujimura, T; Furudate, S; Hashimoto, A; Kambayashi, Y; Ohuchi, K | 1 |
| Aiba, S; Amagai, R; Fujimura, T; Kambayashi, Y; Lyu, C; Ohuchi, K; Sato, Y; Tanita, K | 1 |
| Bagot, M; Battistella, M; Bouaziz, JD; Brice, P; Dangien, A; de Masson, A; Lebbé, C; Moins-Teisserenc, H; Mourah, S; Peffault de Latour, R; Ram-Wolff, C; Roelens, M | 1 |
| Aiba, S; Terui, H; Yamasaki, K; Yoshida, S | 1 |
| Lee, YS; Lin, KW; Phipps, C | 1 |
| Chen, CC; Teng, CL; Yeh, SP | 1 |
| Anhalt, GJ; Hosler, GA; Liégeois, N; Moresi, JM | 1 |
| Alonso-Llamazares, J; Marchione, R; Ricotti, C; Romanelli, P; Shiman, M | 1 |
| Shirakashi, Y; Sugiura, M; Terada, T | 1 |
| Imashuku, S; Kikuchi, A; Konishi, K; Kuroda, H; Maeda, Y; Tamura, S; Teramura, T | 1 |
| Aragane, Y; Hashimoto, K; Isogai, R; Kanamaru, A; Kawada, A; Maeda, Y; Tezuka, T | 1 |
| Bachelez, H; Brice, P; Dubertret, L; Dupuy, A; Janin, A; Lebbé, C; Mebazaa, A; Morel, P; Moulonguet, I; Mouly, F; Rivet, J; Rybojad, M; Vignon-Pennamen, MD | 1 |
| Anan, T; Fujiwara, S; Hatano, Y; Kadota, JI; Kashima, K; Katagiri, K; Ogata, M; Ohishi, M; Senba, K; Takayasu, S; Yasumatsu, T; Yokoyama, S | 1 |
| Assanasen, T; Intragumtornchai, T; Nakorn, TN; Rojnuckarin, P; Wannakrairot, P | 1 |
| Cowpe, JG; Lewis, MA; Thomas, DW | 1 |
| Kawakami, K; Kodama, K; Matsuo, T; Nomura, T; Yamada, T; Yamaoka, M; Yasui, K | 1 |
| Bernengo, MG; Doveil, GC; Fierro, MT; Quaglino, P; Savoia, P; Verrone, A | 1 |
| Abe, R; Fukada, Y; Fukae, J; Katagiri, E; Kobayashi, H; Koike, T; Koizumi, K; Nishio, M; Notoya, A; Sawada, K; Shimizu, T; Tarumi, T | 1 |
| Back, AL; Haycox, CL; Piepkorn, M; Raugi, GJ | 1 |
| Akpek, G; Bogen, S; Foss, FM; Koh, HK; O'Hara, C | 1 |
| Fukuda, N; Muraki, K; Ota, I; Shimohakamada, Y; Shinohara, K | 1 |
| Atiq, OT; DeAngelis, LM; Portlock, CS; Rosenblum, M | 1 |
3 review(s) available for etoposide and Lymphoma, T-Cell, Cutaneous
| Article | Year |
|---|---|
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclosporine; Cytarabine; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Multimodal Imaging; Panniculitis; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Skin Neoplasms; Subcutaneous Fat; Tomography, X-Ray Computed | 2016 |
CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Immunophenotyping; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pruritus; Remission Induction; Vincristine | 2008 |
Therapy-related myelodysplastic syndrome in a case of cutaneous adult T-cell lymphoma.
Topics: Acute Disease; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Japan; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Lymphoma, T-Cell, Cutaneous; Male; Nitrosourea Compounds; Prednisolone; Proviruses; Radiotherapy; Remission Induction; Translocation, Genetic; Vincristine | 2002 |
1 trial(s) available for etoposide and Lymphoma, T-Cell, Cutaneous
| Article | Year |
|---|---|
Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Prednisone; Remission Induction; Sezary Syndrome; Vincristine | 1999 |
18 other study(ies) available for etoposide and Lymphoma, T-Cell, Cutaneous
| Article | Year |
|---|---|
Cutaneous T cell lymphoma treated with mogamulizumab monotherapy and mogamulizumab plus etoposide combined therapy: A real-world case series.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Etoposide; Humans; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Randomized Controlled Trials as Topic; Retrospective Studies; Skin Neoplasms | 2022 |
Successful treatment of mogamulizumab-resistant mycosis fungoides with mogamulizumab plus etoposide combined therapy: Investigation of the immunomodulatory effects of etoposide on the tumor microenvironment.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Etoposide; Humans; Lymphoma, T-Cell, Cutaneous; Mice; Mycosis Fungoides; Skin Neoplasms; Tumor Microenvironment | 2020 |
Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Neoplasm Recurrence, Local; Recurrence; Salvage Therapy | 2020 |
Primary Cutaneous Aggressive Epidermotropic CD8+ T-cell Lymphoma with Brain Involvement and Mimicking Dermatomyositis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Brain Neoplasms; CD8-Positive T-Lymphocytes; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Dermatomyositis; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Male; Predictive Value of Tests; Prednisone; Skin Neoplasms; Transplantation, Homologous; Treatment Outcome; Vincristine | 2018 |
Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell, Cutaneous; Prednisone; Skin Neoplasms; Vincristine | 2014 |
Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Clone Cells; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Cutaneous; Middle Aged; Panniculitis; Prednisone; Receptors, Antigen, T-Cell, gamma-delta; Skin Neoplasms; T-Lymphocytes; Vincristine | 2008 |
T-cell lymphoma of the penis as the first manifestation of adult T-cell lymphoma/leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell, Cutaneous; Male; Maxillary Neoplasms; Middle Aged; Penile Neoplasms; Prednisone; Treatment Outcome; Vincristine | 2012 |
Treatment of Epstein-Barr virus-associated peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Humans; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms | 2004 |
Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Facial Neoplasms; Humans; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Prednisone; Skin Neoplasms; Vincristine | 2004 |
ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cisplatin; Cytarabine; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome | 2005 |
Maintenance of long-term remission using oral administration of low-dose etoposide in a patient demonstrating a relapse of blastic natural killer-cell lymphoma.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Phytogenic; Biopsy; Etoposide; Humans; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Remission Induction; Secondary Prevention; Skin Neoplasms; Treatment Outcome | 2007 |
Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Middle Aged; Panniculitis; Prednisone; Prognosis; Remission Induction; Skin Neoplasms; Treatment Outcome; Vincristine | 2007 |
Cutaneous T-cell lymphoma presenting as facial swelling: report of a case and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cheek; Cyclophosphamide; Etoposide; Facial Neoplasms; Forearm; Humans; Lomustine; Lymphoma, T-Cell, Cutaneous; Male; Prednisolone; Skin Neoplasms | 1994 |
[Successful combination chemotherapy including deoxycoformycin in a case of cutaneous T cell lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dermatitis, Exfoliative; Etoposide; Female; Humans; Lymphoma, T-Cell, Cutaneous; Pentostatin; Vincristine | 1996 |
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Prednisone; Remission Induction; Sezary Syndrome; Skin Neoplasms; Vincristine | 1997 |
Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Cutaneous; Male; Panniculitis, Nodular Nonsuppurative; Prednisone; Remission Induction; Terminology as Topic; Vincristine | 1997 |
Subcutaneous T-cell lymphoma treated with systemic chemotherapy, autologous stem cell support, and limb amputation.
Topics: Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leg; Lymphoma, T-Cell, Cutaneous; Male; Prednisone; Radiotherapy Dosage; Recombinant Proteins; Remission Induction; Vincristine; Whole-Body Irradiation | 1997 |
Cutaneous T-cell lymphoma presenting with diffuse lymphomatous infiltration of the peripheral nerves: response to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Etoposide; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Invasiveness; Peripheral Nervous System Neoplasms; Remission Induction; Skin Neoplasms | 1992 |